Computational Methods Reveal How Hospital-Acquired Bacteria Spread
Scientists at the Academy of Finland's Centre of Excellence in Computational Inference Research have developed novel computational methods that have yielded essential knowledge of how hospital-acquired bacteria spread and develop. These new methods, based on randomised algorithms, make it possible to analyse extensive genomic data significantly faster and more efficiently than previously. By applying these results, it is possible to better follow hospital-acquired infections in the future, or even fight them in real time.
The new methods are used to develop models of the evolution of bacteria and viruses. "Essential for the evolution of the bacteria that cause hospital-acquired infections is the horizontal gene transfer. It means that several different cell processes transfer genes between the lineages of the same and different species so that the bacterium becomes resistant to antibiotics and the virulence factor rapidly spreads in the population," explains group leader, Professor Jukka Corander. Corander's group is part of the Centre of Excellence in Computational Inference Research.
This so-called recombination of bacteria makes it much more complicated to carry out evolution analyses. To facilitate such analyses, Corander's group in cooperation with researchers from Harvard University and the Wellcome Trust Sanger Institute has developed a number of methods based on smart randomised algorithms. These methods facilitate efficient and reliable analyses of extensive genomic data. With the current, most commonly used computational methods this work would take several months or even several years.
Two of the group's methods have recently been applied by an international study. This study demonstrated that more than half of the genetic variation of the MRSA bacteria (i.e. methicillin-resistant strains of Staphylococcus aureus) is caused by horizontal genomic transfer. This shows that the evolutionary analyses of the strains of bacteria are necessary when investigating the spread of bacteria in a host population. This horizontal variation significantly distorts the results received from normal evolutionary analyses.
"On the basis of the results from these analyses, i.e. the evolutionary variation, we're able to estimate when a certain strain of the MRSA bacterium has entered a country and started to spread to hospitals. This is the first time we have been able to prove that the interplay between the horizontal genomic variation and the mutational genomic variation may vary significantly across geographical locations and even between individual hospitals," Corander says. According to Corander, these insights open up new opportunities for in-depth studies on the spread and variation of MRSA and related causalities.
In another recently published study, Corander's group investigated the origin and evolution of the Enterococcus faecium bacterium that has adapted to survive in hospital environments. By using its analysis methods, the group found out that the forms of the bacteria originate from several independent sources, which is contrary to previous knowledge. In the nuclear genome of hospital strains of E. faecium, fewer signs of horizontal transfer were found than expected. This discovery led to a hypothesis that strains of bacteria that have adapted to survive in hospital environments may become either genetically or ecologically more isolated after horizontal transfer.
MRSA is a globally spread bacterium that is especially troublesome in hospitals. It is resistant to most antibiotics and annually causes the death of tens of thousands of people in the US, for instance. According to cautious estimates, the annual costs incurred by MRSA infections amount to several billion US dollars. In recent years, the E. faecium bacterium has become one of the major causes of hospital-acquired infections and its antibiotic-resistant strains have caused severe hospital epidemics worldwide.
Santiago Castillo-Ramirez, Jukka Corander, Pekka Marttinen, Mona Aldeljawi, William P Hanage, Henrik Westh, Kit Boye, Zeynep Gulay, Stephen D Bentley, Julian Parkhill, Matthew T Holden and Edward J Feil
Phylogeographic variation in recombination rates within a global clone of Methicillin-Resistant Staphylococcus aureus (MRSA) Genome Biology, 13:R126 doi:10.1186/gb-2012-13-12-r126.
Rob J. L. Willems, Janetta Top, Willem van Schaik, Helen Leavis, Marc Bonten, Jukka Sirén, William P Hanage and Jukka Corander
Restricted gene flow among hospital subpopulations of Enterococcus faecium. mBio, 3, e00151-12.
Most Popular Now
Medelinked is now integrated with Microsoft Health and Band. The integration ensures that wellness summary data from Microsoft Health app and Band wearable is available i...Read more
21 - 22 November 2016, Barcelona, Spain. The European Connected Health Alliance (ECHAlliance) and Personal Connected Health Alliance (PCHA) have signed a pivotal agreeme...Read more
Nervecentre Software has launched a mobile clinical photography solution for nurses and doctors in hospitals. Fully integrated directly into the patient record, the mobil...Read more
The term 'in silico clinical trials' refers to: "The use of individualised computer simulation in the development or regulatory evaluation of a medicinal product, medica...Read more
During the 2014 FIFA World Cup opening ceremony, a young Brazilian man, paralyzed from the chest down, delivered the opening kickoff. He used a brain-machine interface, a...Read more
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patie...Read more
INSIGHTEC, the global leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced the signing of a strategic agreement with the global leader in Magnetic Resonance...Read more
Agfa HealthCare, a leader and innovator in the medical imaging and healthcare IT space, today announced that the U.S. government has awarded the company its DIN-PACS IV (...Read more
22 August 2016, Berlin, Germany. The Grants4Apps® Accelerator is a mentoring program for digital health startups taking place in Berlin. This year's batch with five star...Read more